F059 Behind the Bra: What Dermatologist Should Know about Diseases of the Breast
DESCRIPTION
Skin disease of the breast, including inflammatory, infectious and neoplastic entities, affects many of our patients. Idiopathic granulomatous mastitis will be reviewed including the clinical presentation, occasional co-morbidities, and treatment. We will teach how to evaluate a lactating patient with nipple pain from dermatitis or infection or Raynauds. Breast cancer and the effects of radiation on the breast, including delayed effects, will be discussed. Recognition of dermatologic issues arising from procedures performed in our transgender/gender non- binary patients will be highlighted.
LEARNING OBJECTIVES
Identify and treat inflammatory diseases of the breast such as idiopathic granulomatous mastitis.
Determine causes of pain in the breast during lactation including infectious etiologies.
Identify changes in the breast associated with treatment for breast cancer.
SCHEDULE
1:00 PM
Introduction
Miriam Keltz Pomeranz, MD, FAAD
1:05 PM
Inflammatory Diseases of the Breast
Miriam Keltz Pomeranz, MD, FAAD
1:20 PM
Questions and Answers
Miriam Keltz Pomeranz, MD, FAAD
1:25 PM
Malignancies of the Breast
Jonathan Scott Leventhal, MD, FAAD
1:45 PM
Questions and Answers
Jonathan Scott Leventhal, MD, FAAD
1:50 PM
Adverse Effects of Breast Cancer Treatment
Beth McLellan, MD, FAAD
2:10 PM
Questions and Answers
Beth McLellan, MD, FAAD
2:15 PM
Concerns with Breasts in Transgender Patients
Matthew David Mansh, MD, FAAD
2:30 PM
Questions and Answers
Matthew David Mansh, MD, FAAD
2:35 PM
The Breast in Pregnancy and Lactation
Jenny Eileen Murase, MD, FAAD
2:55 PM
Questions and Answers
DIRECTOR
Miriam Keltz Pomeranz, MD, FAAD
SPEAKERS
Jonathan Scott Leventhal, MD, FAAD
Matthew David Mansh, MD, FAAD
Beth McLellan, MD, FAAD
Jenny Eileen Murase, MD, FAAD
HANDOUTS
DISCLOSURES
Jonathan Scott Leventhal, MD, FAAD
Azitra, Inc – Investigator(Grants/Research Funding); La Roche Posay Dermatologique – Advisory Board(Honoraria); OnQuality Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria);
Matthew David Mansh, MD, FAAD
No financial relationships exist with ineligible companies.
Beth McLellan, MD, FAAD
Bristol Myers Squibb – Investigator(Grants/Research Funding); Hoth Therapeutics – Investigator(Grants/Research Funding); Kintara Therapeutics, Inc. – Investigator(Grants/Research Funding); OnQuality Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Paula's Choice – Advisory Board(Honoraria); Paxman – Investigator(Equipment); Pfizer Inc. – Other(Grants/Research Funding); RBC Consultants – Advisory Board(Honoraria); Spruce – Advisory Board(Stock Options); UpToDate – Other(Fees);
Jenny Eileen Murase, MD, FAAD
AbbVie – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Honoraria); Blueprint Medicines – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker/Faculty Education(Honoraria); Galderma – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Leo Pharma – Advisory Board(Honoraria); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Speaker/Faculty Education(Honoraria); Sanofi – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Honoraria), Speaker/Faculty Education(Honoraria); UpToDate – Consultant(Honoraria);
Miriam Keltz Pomeranz, MD, FAAD
Procter & Gamble Company – Advisory Board(Fees); UpToDate – Other(Patent royalties or other compensation for Intellectual Property Rights);